The pharmaceutical industry is undergoing a big change. The industry is going through a big phase due to disruptive technologies. Mathai Mammen, Global Head of R&D at Janssen, spoke at the MIT AIDM conference on active disruption in Pharma.
Posting on his Linkedin, he states: “I believe strongly that the impact of the increasing availability of new data types, large data sets and advanced computational methods can fundamentally transform how we make medicines and vaccines. The leaders in this revolution will be those that are bilingual – those that speak the languages of data science AND science. At Janssen we are attracting a body of extraordinary people and driving solutions every day to real problems that fulfill our mission of creating medicines that change the directory of health for humanity. Come join us in our mission!”